<unk>  is a rare benign bone tumor accounting for approximately 1% of all benign bone tumors.<unk>  affects all age groups. It is more commonly seen during the second and third decades of life. Men are more commonly affected than women.<unk>  arising from the physeal remnant is the commonly proposed theory in the pathogenesis of this tumor. It is predominantly found in the metaphyses of the long bones. The bones involved include tibia, distal femur, pelvis, feet and hands. Chromosome 6 appears to be involved in<unk> . Over expression of the glutamate receptor gene GRM1 in patients with<unk>  via promoter swapping and gene fusion has been observed. The hallmark of<unk>  is pain, swelling, and pathological fracture. The mainstay of treatment for<unk>  is surgery (curettage and bone grafting).
Chondromyxoid fibroma
Elastofibroma
Nonossifying fibroma
Ossifying fibromyxoid tumour
Fibroma
Angiofibroma
Chondroma
Chondrosarcoma